Seach Medical Group Ltd (TLV:SEMG)
266.00
-8.00 (-2.92%)
Aug 3, 2026, 5:24 PM IDT
Seach Medical Group Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 88 | 89 | 103 | 60 | 62 | 123 | |
Market Cap Growth | -2.41% | -13.24% | 72.50% | -4.00% | -49.59% | -42.62% |
Enterprise Value | 81 | 95 | 124 | 90 | 71 | 109 |
Last Close Price | 2.75 | 2.51 | 2.68 | 1.55 | 1.62 | 3.21 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.80 | 58.54 | 7.60 | - | - | 23.03 |
PS Ratio | 0.56 | 0.57 | 0.60 | 0.40 | 0.46 | 1.83 |
PB Ratio | 0.89 | 0.90 | 1.00 | 0.67 | 0.61 | 1.29 |
P/TBV Ratio | 1.19 | 1.19 | 1.49 | 1.13 | 1.13 | 1.84 |
P/FCF Ratio | 4.61 | 5.43 | 6.62 | - | 3.84 | - |
P/OCF Ratio | 4.36 | 5.09 | 6.31 | 264.93 | 3.57 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.51 | 0.60 | 0.72 | 0.60 | 0.53 | 1.62 |
EV/EBITDA Ratio | 4.44 | 6.69 | 5.82 | 69.87 | 7.65 | 14.73 |
EV/EBIT Ratio | 5.64 | 7.62 | 6.53 | - | 17.61 | 24.69 |
EV/FCF Ratio | 4.22 | 5.76 | 7.96 | - | 4.39 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.14 | 0.17 | 0.19 | 0.26 | 0.28 | 0.15 |
Debt / EBITDA Ratio | 0.75 | 1.03 | 0.82 | 5.53 | 2.62 | 1.80 |
Debt / FCF Ratio | 0.74 | 1.02 | 1.27 | - | 1.75 | - |
Net Debt / Equity Ratio | -0.18 | -0.11 | 0.02 | 0.14 | 0.06 | -0.08 |
Net Debt / EBITDA Ratio | -1.06 | -0.81 | 0.09 | 9.75 | 0.69 | -1.05 |
Net Debt / FCF Ratio | -0.92 | -0.70 | 0.12 | -18.93 | 0.40 | 0.77 |
Asset Turnover | 1.10 | 1.10 | 1.24 | 1.03 | 0.92 | 0.61 |
Inventory Turnover | 3.01 | 2.73 | 3.23 | 3.23 | 2.67 | 1.65 |
Quick Ratio | 2.05 | 1.63 | 1.48 | 1.32 | 1.27 | 1.61 |
Current Ratio | 3.31 | 3.49 | 3.15 | 2.77 | 2.46 | 3.15 |
Return on Equity (ROE) | 4.60% | 0.35% | 14.13% | -12.46% | -5.34% | 5.98% |
Return on Assets (ROA) | 6.56% | 5.42% | 8.53% | -1.01% | 1.74% | 2.49% |
Return on Invested Capital (ROIC) | 13.55% | 1.14% | 18.37% | -2.26% | 4.12% | 5.15% |
Return on Capital Employed (ROCE) | 13.70% | 11.20% | 16.10% | -2.20% | 3.20% | 4.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.59% | 1.71% | 13.15% | -17.63% | -5.49% | 4.34% |
FCF Yield | 21.68% | 18.42% | 15.12% | -1.12% | 26.02% | -8.14% |
Dividend Yield | 6.57% | 7.17% | 4.48% | - | - | - |
Payout Ratio | 68.21% | 260.30% | - | - | - | - |
Buyback Yield / Dilution | -8.85% | 1.42% | -0.03% | - | -0.78% | -3.61% |
Total Shareholder Return | -2.28% | 8.59% | 4.45% | - | -0.78% | -3.61% |